Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Pharmacokinetics in Critically Ill Patients Undergoing CRRT
NCT02081560Phase 4Unknown
- Sponsor
- University of Zurich
- Start
- Nov 2013
- Primary completion
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistin in Gram-negative bacterial infection, sponsored by University of Zurich. Primary endpoint: Area under the curve at 8 hours. Status: unknown.
02
Drugs
colistin
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT02081560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081560.